Int Health. 2020 Oct 31:ihaa088. doi: 10.1093/inthealth/ihaa088. Online ahead of print.ABSTRACTBACKGROUND: There may be a difference in the number of
Clin Exp Med. 2020 Oct 30. doi: 10.1007/s10238-020-00671-y. Online ahead of print.ABSTRACTThe new type of coronavirus (COVID-19), SARS-CoV-2 originated
mBio. 2020 Oct 30;11(6):e01661-20. doi: 10.1128/mBio.01661-20.ABSTRACTThe ultimate outcome of the coronavirus disease 2019 (COVID-19) pandemic is unknown
Med J Aust. 2020 Oct 26. doi: 10.5694/mja2.50831. Online ahead of print.ABSTRACTOBJECTIVES: To estimate the population prevalence of clinically
Ann Oncol. 2020 Oct 21:S0923-7534(20)42965-5. doi: 10.1016/j.annonc.2020.10.473. Online ahead of print.ABSTRACTBACKGROUND: Patients with cancer have high
Chembiochem. 2020 Oct 20. doi: 10.1002/cbic.202000455. Online ahead of print.ABSTRACTThe SARS-CoV-2 pandemic is the biggest health concern today, but
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study. PLoS Med. 2020
Ugeskr Laeger. 2020 Aug 31;182(36):V06200442.ABSTRACTIn the aftermath of COVID-19, the association between SARS-CoV-2 and chemosensory deficits have been
Ugeskr Laeger. 2020 Aug 31;182(36):V06200442.ABSTRACTIn the aftermath of COVID-19, the association between SARS-CoV-2 and chemosensory deficits have been
Mol Neurobiol. 2020 Sep 25. doi: 10.1007/s12035-020-02134-7. Online ahead of print.ABSTRACTThe main discussion above of the novel pathogenic severe acute